Overview
Zhiwen Zeng practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Rhabdomyosarcoma, Methicillin-Resistant Staphylococcus Aureus (MRSA), Nasopharyngeal Carcinoma, and Endoscopy.
They are actively involved in clinical research, co-authoring 39 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhiwen Zeng
Is Zhiwen Zeng a top-rated expert for Rhabdomyosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Zhiwen Zeng is classified as an Experienced expert for Rhabdomyosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhiwen Zeng participate in research or clinical trials?
Yes. Zhiwen Zeng has published 39 articles and abstracts on conditions like Rhabdomyosarcoma. You can view a list of Zhiwen Zeng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EndoscopyZeng isExperienced. Learn about Endoscopy.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Nasopharyngeal CarcinomaZeng isExperienced. Learn about Nasopharyngeal Carcinoma.
- RhabdomyosarcomaZeng isExperienced. Learn about Rhabdomyosarcoma.